News
Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...
Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...
GLP-1s are bringing many changes to people's lives. An unexpected and less welcome one? A newfound aversion to meat and other ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
Inovia Pharmacy Yasser from Inovia Pharmacy joined Studio 17 host Kait Hill to discuss the rising popularity of GLP-1 ...
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results